Merck & Co., Inc. (MRK) Short Interest Ratio & Short Volume → The new financial threat that could wipe out millions… (From InvestorPlace) (Ad) Free MRK Stock Alerts $129.48 -0.90 (-0.69%) (As of 05/8/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Merck & Co., Inc. Short Interest DataCurrent Short Volume20,430,000 sharesPrevious Short Volume19,590,000 sharesChange Vs. Previous Month+4.29%Dollar Volume Sold Short$2.58 billionShort Interest Ratio / Days to Cover2.5Last Record DateApril 15, 2024Outstanding Shares2,533,030,000 sharesPercentage of Shares Shorted0.81%Today's Trading Volume6,658,813 sharesAverage Trading Volume8,184,872 sharesToday's Volume Vs. Average81% Short Selling Merck & Co., Inc. ? Sign up to receive the latest short interest report for Merck & Co., Inc. and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatMRK Short Interest Over TimeMRK Days to Cover Over TimeMRK Percentage of Float Shorted Over Time Ad InvestorPlace$21,000 in profits in six weeks? On Wednesday, May 8, the legendary Jonathan Rose is holding his first ever Masters in Trading Summit. Jonathan is one of the sharpest traders I’ve ever met. He made millions trading in the pits of the world’s largest exchanges.Click here for details. Merck & Co., Inc. Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/202420,430,000 shares $2.58 billion +4.3%N/A2.5 $126.19 3/31/202419,590,000 shares $2.58 billion -15.4%N/A2.3 $131.95 3/15/202423,160,000 shares $2.81 billion +39.5%N/A2.8 $121.53 2/29/202416,600,000 shares $2.11 billion -1.3%N/A2.1 $127.15 2/15/202416,820,000 shares $2.13 billion -1.2%N/A2 $126.54 1/31/202417,020,000 shares $2.06 billion -18.2%N/A2 $120.78 Get the Latest News and Ratings for MRK and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Merck & Co., Inc. and its competitors with MarketBeat's FREE daily newsletter. 1/15/202420,810,000 shares $2.47 billion +16.5%N/A2.5 $118.63 12/31/202317,870,000 shares $1.95 billion +32.7%N/A2.2 $109.02 12/15/202313,470,000 shares $1.42 billion -19.3%N/A1.7 $105.64 11/30/202316,690,000 shares $1.71 billion -7.4%N/A2.3 $102.48 11/15/202318,020,000 shares $1.83 billion +9.8%N/A2.7 $101.35 10/31/202316,410,000 shares $1.68 billion +3.9%N/A2.5 $102.68 10/15/202315,790,000 shares $1.64 billion +6.5%N/A2.4 $104.01 9/30/202314,830,000 shares $1.53 billion +6.8%N/A2.2 $102.95 9/15/202313,880,000 shares $1.49 billion -5.2%N/A2 $107.47 8/31/202314,640,000 shares $1.60 billion +1.2%N/A2 $108.98 8/15/202314,460,000 shares $1.57 billion +2.3%N/A1.9 $108.66 7/31/202314,140,000 shares $1.51 billion -21.1%N/A1.9 $106.65 7/15/202317,920,000 shares $1.92 billion +6.3%N/A2.5 $107.34 6/30/202316,860,000 shares $1.94 billion +12.7%N/A2.4 $115.36 6/15/202314,960,000 shares $1.64 billion -4.4%N/A2.1 $109.40 5/31/202315,650,000 shares $1.73 billion -20.2%N/A2.1 $110.41 5/15/202319,620,000 shares $2.28 billion +2.7%N/A2.6 $116.37 4/30/202319,100,000 shares $2.21 billion -10.5%N/A2.5 $115.47 4/15/202321,340,000 shares $2.46 billion -3.3%N/A2.6 $115.31 3/31/202322,070,000 shares $2.35 billion +13.0%N/A2.6 $106.39 3/15/202319,540,000 shares $2.10 billion -4.9%N/A2.3 $107.63 2/28/202320,550,000 shares $2.18 billion +5.6%N/A2.4 $106.24 2/15/202319,470,000 shares $2.10 billion +13.5%N/A2.2 $107.68 1/31/202317,150,000 shares $1.84 billion +5.7%N/A1.9 $107.41 1/15/202316,220,000 shares $1.82 billion -5.8%N/A1.7 $112.25 12/30/202217,210,000 shares $1.91 billion -16.1%N/A1.8 $110.95 12/15/202220,510,000 shares $2.25 billion +4.5%N/A2.2 $109.63 11/30/202219,630,000 shares $2.16 billion +0.8%N/A2.1 $110.12 11/15/202219,470,000 shares $1.94 billion -4.4%N/A2.2 $99.60 10/31/202220,360,000 shares $2.06 billion +5.8%N/A2.4 $101.20 10/15/202219,240,000 shares $1.77 billion -5.7%N/A2.3 $92.18 9/30/202220,400,000 shares $1.76 billion +4.9%N/A2.5 $86.12 9/15/202219,450,000 shares $1.69 billion +0.8%N/A2.2 $86.75 8/31/202219,290,000 shares $1.65 billion -2.4%N/A2 $85.36The Weight Loss Pill That Could Disrupt a $32 Billion Industry (Ad)A revolutionary new weight loss pill is about to send shockwaves through the plus-size clothing market. Analysts are calling it the "King Kong" of diet drugs after amazing clinical trial results.Don't miss out on the "next Ozempic" >>> MRK Short Interest - Frequently Asked Questions What is Merck & Co., Inc.'s current short interest? Short interest is the volume of Merck & Co., Inc. shares that have been sold short but have not yet been covered or closed out. As of April 15th, investors have sold 20,430,000 shares of MRK short. Learn More on Merck & Co., Inc.'s current short interest. What is a good short interest ratio for Merck & Co., Inc.? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. MRK shares currently have a short interest ratio of 2.0. Learn More on Merck & Co., Inc.'s short interest ratio. Which institutional investors are shorting Merck & Co., Inc.? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Merck & Co., Inc.: MAI Capital Management, BNP Paribas Financial Markets, Concourse Financial Group Securities Inc., SpiderRock Advisors LLC, Oak Hill Wealth Advisors LLC, Simplex Trading LLC, Readystate Asset Management LP, Parallax Volatility Advisers L.P., BlueCrest Capital Management Ltd, Citadel Advisors LLC, Point72 Asset Management L.P., Balyasny Asset Management L.P., Eisler Capital US LLC, Eisler Capital UK Ltd., Capstone Investment Advisors LLC, Allianz Asset Management GmbH, Mendel Money Management, IMC Chicago LLC, One River Asset Management LLC, Wells Fargo & Company MN, and UBS Group AG. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is Merck & Co., Inc.'s short interest increasing or decreasing? Merck & Co., Inc. saw a increase in short interest in April. As of April 15th, there was short interest totaling 20,430,000 shares, an increase of 4.3% from the previous total of 19,590,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Merck & Co., Inc.'s short interest compare to its competitors? Here is how the short interest of companies in the sector of "medical" compare to Merck & Co., Inc.: Johnson & Johnson (0.69%), AbbVie Inc. (0.77%), Pfizer Inc. (1.20%), Bristol-Myers Squibb (1.69%), Eli Lilly and Company (0.65%), AstraZeneca PLC (0.28%), Novartis AG (0.19%), Abbott Laboratories (0.75%), Sanofi (0.13%), Regeneron Pharmaceuticals, Inc. (1.27%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short Merck & Co., Inc. stock? Short selling MRK is an investing strategy that aims to generate trading profit from Merck & Co., Inc. as its price is falling. MRK shares are trading down $0.90 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Merck & Co., Inc.? A short squeeze for Merck & Co., Inc. occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of MRK, which in turn drives the price of the stock up even further. How often is Merck & Co., Inc.'s short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including MRK, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: JNJ Short Squeeze ABBV Short Squeeze PFE Short Squeeze BMY Short Squeeze LLY Short Squeeze AZN Short Squeeze NVS Short Squeeze ABT Short Squeeze SNY Short Squeeze REGN Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NYSE:MRK) was last updated on 5/8/2024 by MarketBeat.com Staff From Our PartnersThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySmallcaps DailyTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaAI “wealth window” is closing June 25thParadigm PressThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldHe Is Giving Away BitcoinCrypto Swap ProfitsGold Set to EXPLODE!Gold Safe ExchangeCharles Payne Demystifies OptionsUnstoppable ProsperityShocking: One AI startup's revenue could surge 4,735%Manward Press